27.19USD-2.96%Mkt Cap: 1.31B USDP/E: —Last update: 2026-06-01
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers. It offers RTGel, a novel proprietary polymeric biocompatible, reverse therm…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.31B USD
Enterprise Value1.43B USD
Revenue (TTM)140.49M USD
Gross Profit97.34M USD
Net Income (TTM)-153.49M USD
Revenue/Share2.879 USD
Last Price27.19 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees298
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)22.89
PEG—
EV/EBITDA-13.23
EV/Revenue10.16
P/S9.76
P/B-11.03
EPS (TTM)-2.74
EPS (Forward)1.23
52W Range
3.60582% of range32.37
52W High32.37 USD
52W Low3.605 USD
Profitability
Gross Margin88.66%
Oper. Margin-39.76%
EBITDA Margin-76.80%
Profit Margin-139.81%
ROE145.53%
ROA-76.57%
Growth
Revenue Growth151.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-162.44M USD
CapEx (TTM)289.00K USD
FCF Margin-77.78%
FCF Yield-8.37%
Net Debt56.82M USD
Net Debt/EBITDA-0.53
Balance Sheet
Debt/Equity-1.22
Current Ratio4.69
Quick Ratio3.87
Book Value/Sh-2.5510 USD
Cash/Share2.879 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)36.88 USD
Target Range18.00 USD – 45.00 USD
# Analysts8
Ownership
Shares Out.48.72M
Float43.18M
Insiders3.65%
Institutions99.43%
Short Interest
Short Ratio6.8d
Short % Float14.17%
Short % Out.13.88%
Shares Short6.76M
Short (prev mo.)7.83M
Technical
SMA 5023.71 (+14.7%)
SMA 20021.43 (+26.9%)
Beta1.59
S&P 52W Chg27.70%
Avg Vol (30d)853.33K
Avg Vol (10d)663.42K
Technical Indicators
RSI (14)53.7
MACD1.4666
MACD Signal1.7982
MACD Hist.-0.3316
BB Upper33.10 USD
BB Middle28.24 USD
BB Lower23.38 USD
BB Width34.41%
ATR (14)1.673 USD
Vol Ratio (20d)0.54x